Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F46DU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,914
Award facts
- Contract value 100% obligated
- $15,914.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,914.07 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on December 4, 2025, with completion expected by December 5, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026, which enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems through competitively awarded delivery orders covering diverse therapeutic domains. The company's federal contract portfolio demonstrates consistent capability in fulfilling firm fixed-price orders ranging from minimal to substantial values, supplying medications including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and related medical supplies. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to result in multiple regional awards involving at least three contractors, positioning AmerisourceBergen to continue serving key customers including the Defense Health Agency and U.S. Coast Guard through flexible procurement vehicles.
Quick answers
Who was awarded contract SPE2DR26F46DU?
SPE2DR26F46DU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F46DU worth?
The government has obligated $15,914 on SPE2DR26F46DU.
Is contract SPE2DR26F46DU an order under another contract?
Yes. SPE2DR26F46DU is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46DU competed?
The extent of competition for SPE2DR26F46DU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award